EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Statistical evaluation of absolute change versus responder analysis in clinical trials

Peijin Wang, Sarah Peskoe, Rebecca Byrd, Patrick Smith, Rachel Breslin, Shein-Chung Chow

Acta Materia Medica · 2022 · 1 (3)

DOI: 10.15212/amm-2022-0020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Materia Medica, 2022. Verfasst von Peijin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham North Carolina. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In clinical trials, the primary analysis is often either a test of absolute/relative change in a measured outcome or a corresponding responder analysis. Although each of these tests may be reasonable, determining which test is most suitable for a particular research study remains an open question. These tests may require different sample sizes or define different clinically meaningful differences; most importantly, they may lead to different study conclusions. The aim of this study was to compare a typical non-inferiority test using absolute change as the study endpoint to the corresponding responder analysis in terms of sample-size requirements, statistical power, and hypothesis-testing results. From numerical analysis, using absolute change as an endpoint generally requires a larger sample size; therefore, when the sample size is the same, the responder analysis has higher power. The cut-off value and non-inferiority margin are critical and can meaningfully affect whether the two types of endpoints yield conflicting conclusions. Specifically, extreme cut-off values are more likely to yield different conclusions. However, this influence decreases as population variance increases. One important reason for conflicting conclusions is a non-normal population distribution. To eliminate conflicting results, researchers should consider the population distribution and cut-off value selection.

Schlagwörter

Stichwörter der Autor:innen

Primary EndpointsResponder AnalysisThreshold Selection

Autor:innen und Institutionen

  • Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham North Carolina.
  • Department of Cardiology, Duke Health System, Durham, North Carolina.
  • Department of Psychiatry and Behavioral Sciences, Duke Health System, Durham, North Carolina.

Förderung

  • NCATS NIH HHS

Zitieren

APA

Wang, P., Peskoe, S., Byrd, R., Smith, P., Breslin, R., & Chow, S. C. (2022). Statistical evaluation of absolute change versus responder analysis in clinical trials. Acta Materia Medica, 1(3). https://doi.org/10.15212/amm-2022-0020

Vancouver

Wang P, Peskoe S, Byrd R, Smith P, Breslin R, Chow SC. Statistical evaluation of absolute change versus responder analysis in clinical trials. Acta Materia Medica. 2022;1(3). doi:10.15212/amm-2022-0020

BibTeX
@article{Wang2022,
  author = {Wang, Peijin and Peskoe, Sarah and Byrd, Rebecca and Smith, Patrick and Breslin, Rachel and Chow, Shein-Chung},
  title = {Statistical evaluation of absolute change versus responder analysis in clinical trials},
  journal = {Acta Materia Medica},
  year = {2022},
  volume = {1},
  number = {3},
  doi = {10.15212/amm-2022-0020}
}
Kostenlos starten →